Literature DB >> 10790572

Laser treatment of retinal diseases by subthreshold laser effects.

J Roider1.   

Abstract

The retinal pigment epithelium (RPE) may play an important role in the therapeutic effect of laser photocoagulation. This suggests a benefit from targeting the RPE instead of the sensory retina. Calculating the actual temperature profile after laser photocoagulation, it can be shown that pulse durations have to be in the order of microseconds (micros) to spare the retina from damage. This is consistent with histological findings after laser exposure with repetitive, 5 micros Nd:YLF laser pulses (527 nm). Therapeutic effects have been shown in patients with diabetic macular edema, drusen, and central serous retinopathy.

Entities:  

Mesh:

Year:  1999        PMID: 10790572     DOI: 10.3109/08820539909056059

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  18 in total

1.  Selective retina therapy in patients with central serous chorioretinopathy.

Authors:  H Elsner; E Pörksen; C Klatt; A Bunse; D Theisen-Kunde; R Brinkmann; R Birngruber; H Laqua; J Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

2.  Intravitreal bevacizumab alone versus combined with macular photocoagulation in diabetic macular edema.

Authors:  Soo Jeong Lee; Ei Tae Kim; Yeon Sung Moon
Journal:  Korean J Ophthalmol       Date:  2011-09-20

3.  Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.

Authors:  D S C Lam; W-M Chan; D T L Liu; D S P Fan; W W Lai; K K L Chong
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

4.  Selective retina therapy (SRT) of chronic subfoveal fluid after surgery of rhegmatogenous retinal detachment: three case reports.

Authors:  Stefan Koinzer; Hanno Elsner; Carsten Klatt; Erk Pörksen; Ralf Brinkmann; Reginald Birngruber; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117

5.  Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.

Authors:  Donald S Fong; Samara F Strauber; Lloyd Paul Aiello; Roy W Beck; David G Callanan; Ronald P Danis; Matthew D Davis; Stephen S Feman; Frederick Ferris; Scott M Friedman; Charles A Garcia; Adam R Glassman; Dennis P Han; Darma Le; Craig Kollman; Andreas K Lauer; Franco M Recchia; Sharon D Solomon
Journal:  Arch Ophthalmol       Date:  2007-04

Review 6.  Diabetic macular edema: New promising therapies.

Authors:  Hanan N Al Shamsi; Jluwi S Masaud; Nicola G Ghazi
Journal:  World J Diabetes       Date:  2013-12-15

7.  Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.

Authors:  Emily Y Chew; Jonghyeon Kim; Hanna R Coleman; Lloyd Paul Aiello; Gary Fish; Michael Ip; Julia A Haller; Maria Figueroa; Daniel Martin; David Callanan; Robert Avery; Keri Hammel; Darby J S Thompson; Frederick L Ferris
Journal:  Retina       Date:  2010-03       Impact factor: 4.256

8.  Diabetic macular edema: therapeutic options.

Authors:  Amol D Kulkarni; Michael S Ip
Journal:  Diabetes Ther       Date:  2012-03-06       Impact factor: 2.945

9.  Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema.

Authors:  Rocío Herrero-Vanrell; Jose Augusto Cardillo; Baruch D Kuppermann
Journal:  Clin Ophthalmol       Date:  2011-02-01

10.  Randomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema.

Authors:  W Pei-Pei; H Shi-Zhou; T Zhen; L Lin; L Ying; O Jiexiong; Z Wen-Bo; J Chen-Jin
Journal:  Eye (Lond)       Date:  2015-02-20       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.